Last Price$58.60.7%
Market Cap$29.1B
5.9%
Peers median - 9.5%
(0.3%)
Peers median - 2.3%
69.9%
Peers median - 18.6%
12.0%
Peers median - 4.3%
Competing with CNC
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$29.1B | 5.4 | $1,406.9 2,301.3% undervalued | (25.2%) | $163.1B | ($490.0M) | 5.9% | (0.3%) | 13.1% | 12.0% | 69.9% | |
$436.0B | 5.9 | $1,047.3 124.2% undervalued | (1.6%) | $398.3B | $20.7B | 8.4% | 5.2% | 21.9% | 28.1% | 1.5% | |
$90.7B | 6.7 | $1,001.8 153.3% undervalued | (20.5%) | $176.8B | $4,552.0M | 3.2% | 2.6% | 43.4% | 161.3% | 4.9% | |
$87.2B | 5.8 | $942.9 202.7% undervalued | (6.0%) | $245.3B | $8,957.0M | 25.7% | 3.7% | 48.9% | 4.9% | 77.5% | |
$82.3B | 5.1 | $208.2 220.8% undervalued | (9.3%) | $372.8B | $6,326.0M | 4.2% | 1.7% | 13.8% | 3.7% | 109.5% | |
$31.5B | 6.1 | $797.8 205.0% undervalued | (23.7%) | $117.8B | $2,391.0M | 10.7% | 2.0% | 91.9% | 58.6% | 71.3% | |
$17.3B | 6.3 | $414.9 37.0% undervalued | (21.7%) | $40.6B | $544.0M | 19.2% | 1.3% | 34.7% | 33.0% | 69.4% | |
$3,703.3M | 6.1 | $23.7 57.0% undervalued | (1.7%) | $9,177.6M | $950.3M | 56.6% | 10.4% | 100.0% | (15.2%) | 29.5% | |
$3,104.9M | 5.4 | $8.2 47.0% overvalued | 187.4% | $2,703.6M | ($6,648.0K) | 48.3% | (0.2%) | 33.7% | (41.1%) | 7.8% | |
$1,871.6M | 5.2 | $2.0 45.3% overvalued | 330.8% | $1,370.6M | $128.3M | (32.4%) | 9.4% | 53.9% | 1.2% | 0.0% | |
$65.5M | 5.0 | $46.2 463.3% undervalued | (85.9%) | $1,616.6M | ($2,834.8M) | (71.1%) | (175.4%) | 7.8% | (63.3%) | (145.5%) |
Compare CNC Valuation Multiples with Peers
LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
General
Valuation Multiple
Financial metrics
Company name
EV/Revenue
Revenue growth
EBITDA margin
Net Income margin
Centene CorporationCNC
0.2x
5.9%
27.4%
2.0%
Median Peer Set
0.4x
8.7%
(11.9%)
1.1%
Alignment Healthcare, Inc.ALHC
1.0x
27.2%
(4.8%)
(8.1%)
Bright Health Group, Inc.BHG
N/A
(51.9%)
86.2%
(103.4%)
Cigna CorporationCI
0.5x
8.4%
(18.9%)
2.6%
Clover Health Investments, Corp.CLOV
1.2x
(41.5%)
(31.3%)
(10.5%)
CVS Health CorporationCVS
0.4x
4.2%
(43.6%)
1.2%
Elevance Health Inc.ELV
0.5x
3.2%
(0.0%)
3.4%
Humana Inc.HUM
0.2x
10.7%
(50.1%)
1.0%
Molina Healthcare, Inc.MOH
0.4x
19.3%
9.2%
2.9%
Oscar Health, Inc.OSCR
0.2x
56.5%
N/A
0.3%
UnitedHealth Group IncorporatedUNH
1.0x
8.9%
(35.7%)
3.6%
Compare CNC Valuation Multiples Dynamics with Peers
Crunching data... Almost there!
FAQ
1. How does Centene Corporation (CNC) revenue growth compare to peers and the industry?
Centene Corporation (CNC) revenue growth is 5.9%, compared to the peers' median of 9.5%.
2. How does Centene Corporation (CNC) Free Cash Flow (FCF) margin compare to peers and the industry?
Centene Corporation (CNC) FCF margin is (0.3%), compared to the peers' median of 2.3%.
3. How does Centene Corporation (CNC) Total Debt to Equity ratio compare to peers and the industry?
Centene Corporation (CNC) Total Debt to Equity ratio is 69.9%, compared to the peers' median of 18.6%.
4. How does Centene Corporation (CNC) ROIC (Return on Invested Capital) compare to peers and the industry?
Centene Corporation (CNC) ROIC is 12.0%, compared to the peers' median of 4.3%.